Danitumumab adjunctive therapy. No place in either first- or second-line treatment of metastatic colorectal cancer
Prescrire International 22(138): 120
2013
ISSN/ISBN: 1167-7422 PMID: 23819169 Document Number: 671428
Adding panitumumab to standard protocols does not prolong survival but provokes additional adverse effects.
Document emailed within 1 workday
Related Documents
Lee, J.J.; Sun, W. 2016: Options for Second-Line Treatment in Metastatic Colorectal Cancer Clinical Advances in Hematology and Oncology: H&o 14(1): 46-54Karacetin, D.; Yalcin, B.; Okten, B.; Ozturk, S.; Maral, O.; Incekara, O. 2009: Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 14(4): 605-608
Kemeny, N.E. 2000: Hepatic arterial therapy for the treatment of metastatic colorectal cancer Seminars in Oncology 27(5 Suppl 10: 126-131
Grothey, A. 2015: Maintenance therapy in the treatment of metastatic colorectal cancer. Axel Grothey, MD Oncology 29(8): 560; 594
Grothey, A.; Marshall, J.L.; Bekaii-Saab, T. 2019: Sequencing beyond the second-line setting in metastatic colorectal cancer: further observations Clinical Advances in Hematology and Oncology: H&o 17 Suppl 7(3): 16-18
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Li, J.; Xu, J-Ming.; Li, J.; Zhang, X-Dong.; Bai, Y.; Chu, Y-Ping.; Wang, Y-Hua.; Liu, D-Qi.; Jin, M-Lin.; Shen, L. 2008: Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer Zhonghua Zhong Liu Za Zhi 30(3): 225-227
Hsiao, S-Chuan.; Lin, J-Fen.; Chuang, M-Te.; Lee, Y-An.; Wu, D-Long. 2009: Retrospectively comparative evaluation of the first- and second-line chemotherapy with campto and oxaliplatin combined with oral tegafur/uracil (UFT)/leucovorin (LV) in patients with metastatic colorectal cancer International Surgery 94(4): 298-303
Marshall, J.L. 2014: Maintenance therapy in metastatic colorectal cancer Clinical Advances in Hematology and Oncology: H&o 12(6): 388-390
Turja, J.; Grothey, A. 2008: Individualizing therapy for metastatic colorectal cancer Oncology 22(13): 1479-1481
Pfeiffer, P.; Jensen, B.V. 2005: Drug therapy of patients with metastatic colorectal cancer Ugeskrift for Laeger 167(45): 4261-4265
Matter, M.; Dusmet, M.; Chevalley, F. 2000: The place of surgery in the treatment of advanced localized, recurrent and metastatic breast cancer Revue Medicale de la Suisse Romande 120(6): 485-490
Kato, K. 2011: Development of oral drugs in the standard therapy for metastatic colorectal cancer patients Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 454-458
Maruo, H.; Suzuki, K.; Ishikawa, S.; Murakami, T.; Higashi, Y.; Shoji, T.; Yamazaki, M.; Taniguchi, M.; Nishiyama, R. 2014: Study of S-1 and oxaliplatin(SOX) plus bevacizumab as first-line therapy in patients with unresectable colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(13): 2583-2586
Weinberg, B.A.; Marshall, J.L.; Hartley, M.; Salem, M.E. 2016: A paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancer Clinical Advances in Hematology and Oncology: H&o 14(2): 116-128
Pfeiffer, P.; Qvortrup, C.; Hansen, T.P. 2009: Tailored treatment to patients with metastatic colorectal cancer Ugeskrift for Laeger 171(13): 1098
Takano, J.; Matsuhashi, N.; Takahashi, T.; Tanahashi, T.; Matsui, S.; Imai, H.; Tanaka, Y.; Yamaguchi, K.; Yoshida, K. 2018: A Case of Metastatic Colorectal Cancer with Brain Metastasis Treated with Combined TFTD and Bevacizumab Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(2): 318-320
Baba, S.; Oji, Y.; Teramoto, M.; Kawabata, K.; Saito, A. 2009: A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(11): 1905-1906
Halámková, J.; Tomášek, J.; Rybníčková, S.; Adámková Krákorová, D.; Bencsiková, B.; Kiss, I. 2013: The current approach to the treatment of the patients with metastatic colorectal cancer Vnitrni Lekarstvi 59(10): 903-908
Otani, Y.; Kondo, T.; Saito, R.; Matsumura, Y.; Ohura, H.; Hirose, M.; Horikoshi, A.; Sado, T.; Sugita, M.; Okaniwa, G. 1995: Surgical treatment of metastatic lung tumor from colorectal cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 48(9): 735-740